Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L11 pseudogene 5 (RPL11P5) is a pseudogene in the human genome, related to the functional RPL11 gene that encodes a component of the 60S ribosomal subunit[1][8]. Pseudogenes like RPL11P5 arise through duplication or retrotransposition events and generally do not produce functional proteins, although some pseudogenes may be transcribed[5][9]. Most ribosomal protein pseudogenes (including RPL11P5) do not have a known biological function, are not active in drug targeting, and are not associated with specific disease mechanisms or therapeutic applications[1][8][5][9]. They may, however, occasionally be used as tools or markers in genetic or genomic studies, but evidence for functional impact is lacking. The term “pseudogene” indicates that it is not a gene coding for a functional protein, and it is not considered a valid therapeutic target. RPL11P5 is not a receptor, enzyme, or protein with a defined molecular or therapeutic function; it is a non-functional, processed pseudogene[1][8]. This entry is often included only in genomic catalogs and should not be treated as a drug target unless new evidence demonstrates a functional role.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L11 pseudogene 5 (RPL11P5).